India Set To Impose New Rules On Key Imported Drug Prices
This article was originally published in PharmAsia News
Executive Summary
The Indian government is nearing completion of a set of standards to use in ensuring the prices charged for critical drugs by multinational drug makers are under control. The government considers some of the prices for imported drugs to treat arthritis, diabetes, cancer, heart disease and obesity too high even if they are covered by the government's price control system. The new standards would allow the government to negotiate for certain drugs based on prices charged in other markets. (Click here for more